These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37695664)

  • 1. Association of regulatory T cells with renal outcomes in patients with proliferative lupus nephritis.
    Wang J; Zhu M; Jiao C; Xu X; Xu F; Liang D; Liu Z; Chen Y; Zhang H
    Lupus; 2023 Oct; 32(11):1237-1244. PubMed ID: 37695664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission and long-term outcomes of proliferative lupus nephritis: retrospective study of 96 patients from Saudi Arabia.
    Almalki AH; Alrowaie FA; Alhozali HM; Almalki NK; Alsubei AI; Alturki MS; Sadagah LF
    Lupus; 2019 Aug; 28(9):1082-1090. PubMed ID: 31296138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical manifestations, prognosis, and treat-to-target assessment of pediatric lupus nephritis.
    Qiu S; Zhang H; Yu S; Yang Q; Zhang G; Yang H; Li Q; Wang M
    Pediatr Nephrol; 2022 Feb; 37(2):367-376. PubMed ID: 34379208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term renal outcomes of patients with non-proliferative lupus nephritis.
    Kang ES; Ahn SM; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
    Korean J Intern Med; 2023 Sep; 38(5):769-776. PubMed ID: 37545141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of renal response parameters for juvenile membranous plus proliferative lupus nephritis versus isolated proliferative lupus nephritis: a cross-sectional analysis of the CARRA Registry.
    Boneparth A; Ilowite NT;
    Lupus; 2014 Aug; 23(9):898-904. PubMed ID: 24729278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of membranous and proliferative lupus nephritis - analysis of a single-centre cohort with more than 30 years of follow-up.
    Farinha F; Pepper RJ; Oliveira DG; McDonnell T; Isenberg DA; Rahman A
    Rheumatology (Oxford); 2020 Nov; 59(11):3314-3323. PubMed ID: 32303057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis.
    Häyry A; Faustini F; Zickert A; Larsson A; Niewold TB; Svenungsson E; Oke V; Gunnarsson I
    Lupus Sci Med; 2022 Sep; 9(1):. PubMed ID: 36104119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting outcome and prognosis in membranous lupus nephropathy.
    Mercadal L; Montcel ST; Nochy D; Queffeulou G; Piette JC; Isnard-Bagnis C; Martinez F
    Nephrol Dial Transplant; 2002 Oct; 17(10):1771-8. PubMed ID: 12270983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early predictors of outcomes in pediatric lupus nephritis: focus on proliferative lesions.
    Wu JY; Yeh KW; Huang JL
    Semin Arthritis Rheum; 2014 Feb; 43(4):513-20. PubMed ID: 23972330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis.
    Kwon OC; Park JH; Lee SW; Song JJ; Park YB; Park MC
    Yonsei Med J; 2020 Nov; 61(11):951-957. PubMed ID: 33107238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term renal outcome and complications in South Africans with proliferative lupus nephritis.
    Ayodele OE; Okpechi IG; Swanepoel CR
    Int Urol Nephrol; 2013 Oct; 45(5):1289-300. PubMed ID: 23306862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of tubulointerstitial lesions in predicting renal outcome among pediatric onset lupus nephritis - A retrospective cohort study.
    Wu CY; Chien HP; Yang HY; Yao TC; Tseng MH; Yu MC; Yeh KW; Huang JL
    J Microbiol Immunol Infect; 2020 Feb; 53(1):33-41. PubMed ID: 29289551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mangiferin Attenuates Murine Lupus Nephritis by Inducing CD4+Foxp3+ Regulatory T Cells via Suppression of mTOR Signaling.
    Liang CL; Lu W; Zhou JY; Chen Y; Zhang Q; Liu H; Qiu F; Dai Z
    Cell Physiol Biochem; 2018; 50(4):1560-1573. PubMed ID: 30359968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Crescentic Implication of Renal Outcomes in Proliferative Lupus Nephritis.
    Cai F; Han F; Wang H; Han H; Le J; Lan L; Xu Y; Chen J
    J Rheumatol; 2018 Apr; 45(4):513-520. PubMed ID: 29449502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney thrombotic microangiopathy in lupus nephritis: Impact on treatment and prognosis.
    Massicotte-Azarniouch D; Kotzen E; Todd S; Hu Y; Hogan SL; Jain K
    Lupus; 2022 Sep; 31(10):1175-1185. PubMed ID: 35650019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes in refractory lupus nephritis: Data from an observational study.
    Gururani S; Devarasetti PK; Uppin M; Rajasekhar L
    Lupus; 2021 Oct; 30(11):1725-1731. PubMed ID: 34304627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis.
    Gatto M; Radice F; Saccon F; Calatroni M; Frontini G; Trezzi B; Zen M; Ghirardello A; Tamborini F; Binda V; L'Imperio V; Doria A; Vaglio A; Sinico RA; Moroni G; Iaccarino L
    Lupus Sci Med; 2022 May; 9(1):. PubMed ID: 35568438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and long-term outcomes in patients with mixed Class III/IV + V and pure proliferative lupus nephritis: A single-center experience.
    Ahn SS; Yoo J; Lee SW; Song JJ; Park YB; Jung SM
    Lupus; 2022 Apr; 31(5):588-595. PubMed ID: 35316102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience.
    Duran E; Yıldırım T; Taghiyeva A; Bilgin E; Arıcı M; Sağlam EA; Özen S; Üner M; Erdem Y; Kalyoncu U; Ertenli AI
    Lupus; 2022 Aug; 31(9):1147-1156. PubMed ID: 35658643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.